Feature Channels: Infectious Diseases

Filters close
Released: 14-Jun-2024 5:05 PM EDT
Improving access to HPV testing
Michigan Medicine - University of Michigan

Initiative aims to raise awareness of a cancer-causing virus

Not for public release

This news release is embargoed until 10-Jun-2024 5:00 PM EDT Released to reporters: 4-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Engaging With Patients for Better Treatments and Outcomes for Smell and Taste Disorders
Released: 10-Jun-2024 3:05 PM EDT
Engaging With Patients for Better Treatments and Outcomes for Smell and Taste Disorders
Monell Chemical Senses Center

in 2022 collaborators - patient groups, basic researchers, and clinicians - conducted a survey and listening sessions with patients, caregivers, and family members affected by impaired smell or taste. They asked about their individual perceptions of the effectiveness of treatments, among other topics.

Released: 10-Jun-2024 1:05 PM EDT
Does Your Child Need Travel Vaccines Before an International Trip?
Children's Hospital Los Angeles

If you’re planning an international trip with your child, you may be wondering what vaccines they need and when they should get them. Before you head out of the country, it’s essential to make sure your child is up to date on all of their routine immunizations, including vaccines for COVID-19, flu and RSV.

Newswise: Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
5-Jun-2024 5:05 PM EDT
Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
University of California, Los Angeles (UCLA), Health Sciences

Mpox continues to circulate in the U.S. among gay and bisexual men who have sex with men. Though the number fell sharply to only 3 cases during the June through December 2023 multisite surveillance period compared to the previous highs, concern for its reemergence continues due to, among other things, incomplete knowledge among other groups.

Released: 6-Jun-2024 12:05 PM EDT
Minimally invasive blood collection could advance health equity for people experiencing homelessness
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new study demonstrates that minimally invasive blood collection devices could increase the participation of people experiencing homelessness (PEH) in public health studies and clinical research.

Newswise: 1920_immune-system-cedars-sinai.jpg?10000
Released: 6-Jun-2024 12:05 PM EDT
Cedars-Sinai Investigators Discover Mechanisms of Immunity
Cedars-Sinai

A novel study, led by the Department of Biomedical Sciences at Cedars-Sinai and published today in the peer-reviewed journal Nature, shows how cells use a protein called PD-L1 to rally white blood cells to battle infections.

Released: 3-Jun-2024 3:05 PM EDT
Societal and biological factors both contribute to mental health issues in the wake of COVID-19
University of Chicago Medical Center

Healthcare teams and researchers have documented an increase in mental health issues since the beginning of the COVID-19 pandemic. UChicago experts explore these trends and discuss how biological and societal factors alike can contribute.

Newswise: Antibodies may aid effort to fight influenza B: study
Released: 31-May-2024 2:05 PM EDT
Antibodies may aid effort to fight influenza B: study
Vanderbilt University Medical Center

Researchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children, the elderly and other immunocompromised individuals.

Released: 30-May-2024 7:05 PM EDT
AI model confirms vaccination is key to cutting COVID in prisons
University of South Australia

A team of scientists has developed an artificial intelligence (AI)-based transmission model that can predict prison infection rates with high accuracy. Incorporating real-world data from every facility in the NSW prison system, the new findings add weight to current theoretical models.

29-May-2024 3:05 PM EDT
Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later
Washington University in St. Louis

New findings on long COVID by Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system reveal that COVID-19 patients who were hospitalized within the first 30 days after infection face a 29% higher risk of death in the third year post-infection compared with people who have not had the virus.

Released: 27-May-2024 3:05 PM EDT
Governments Fail to Reach Consensus on Pandemic Prevention Agreement
Wildlife Conservation Society

Member states of the World Health Organization (WHO) did not reach consensus on a new agreement or treaty on pandemic prevention, preparedness, and response.

   
Newswise: What to Know About Bird Flu
Released: 24-May-2024 4:05 PM EDT
What to Know About Bird Flu
University of Utah Health

So far, only two people have been infected with a new strain of H5N1 due to exposure to cows. But the large number of infected cows, their proximity to humans, and flu's tendency to jump from one host to another have scientists and health officials concerned.

Newswise: How COVID-19 'breakthrough' infections alter your immune cells
Released: 24-May-2024 12:05 PM EDT
How COVID-19 'breakthrough' infections alter your immune cells
La Jolla Institute for Immunology

Repeated vaccination and infection leads T cells and B cells to build an "immunity wall"

Released: 24-May-2024 10:05 AM EDT
Raw milk containing H5N1 can infect mice, while lab-based heat treatments greatly reduce the virus
University of Wisconsin–Madison

Consuming raw cow's milk that contains H5N1 avian influenza virus poses an infection risk, but a laboratory process that simulates high-temperature pasteurization reduces the virus in infected milk by more than 99.99%. That's according to a team led by University of Wisconsin–Madison scientists, who reported their findings May 24 in a letter published in the New England Journal of Medicine.

Released: 24-May-2024 10:05 AM EDT
What’s at Stake With the U.S. Supreme Court Case on Misinformation?
Harvard Medical School

Concerns over medical misinformation are not new, but the COVID-19 pandemic magnified long-simmering tensions over two fundamental concepts: Freedom of speech and the federal government’s responsibility to protect people from what it considers false and dangerous claims.

   
Released: 23-May-2024 9:05 AM EDT
Penn Researchers Develop Experimental mRNA Avian Flu Vaccine
Perelman School of Medicine at the University of Pennsylvania

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models. The vaccine could potentially help manage the outbreak of the H5N1 virus currently circulating in birds and cattle in the United States, and prevent human infections with the virus.

21-May-2024 6:05 AM EDT
Research reveals more people died from hot or cold weather conditions than COVID-19 in parts of UK
University of Bristol

Research has highlighted how weather extremes worsened by climate change are now a major national public health threat.

Newswise:Video Embedded advancements-in-pediatric-respiratory-medicine-insights-from-leading-researchers
VIDEO
13-May-2024 9:40 AM EDT
VIDEO and TRANSCRIPT: RSV Risk And Undertreated Asthma: Expert Panel Q&A
Newswise

Doctors with the American Thoracic Society will discuss new research about the potential effect of estrogen on hypertension for women in menopause, and the link between hormone replacement and breast cancer risk. How can patients and doctors weigh the risks and benefits and decide whether or not estrogen is right for them?

13-May-2024 9:00 AM EDT
New Tool May Help Prioritize High-Risk Infants for RSV Immunization
American Thoracic Society (ATS)

Pediatric Impact of COVID-19 and Other Respiratory Infections Clinical Prediction Tool for Prioritizing Respiratory Syncytial Virus Prevention Products for High-Risk Infants During Current Limited Availability of Nirsevimab in the United States

Newswise: Study that empowers traditional health practitioners to test for HIV expands in rural South Africa
Released: 21-May-2024 3:05 AM EDT
Study that empowers traditional health practitioners to test for HIV expands in rural South Africa
University of the Witwatersrand, Johannesburg

A National Institutes of Health five-year, $2.8 million grant to Wits and Vanderbilt University will advance traditional health practitioner-initiated HIV testing.

Not for public release

This news release is embargoed until 20-May-2024 5:00 PM EDT Released to reporters: 14-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-May-2024 11:05 AM EDT
Is a Global Pandemic Prevention Pact Within Reach?
Harvard Medical School

The World Health Organization’s governing body is scheduled to meet on May 27 to discuss a critically needed plan for global pandemic preparedness.

Newswise: Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Released: 20-May-2024 10:05 AM EDT
Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Binghamton University, State University of New York

What’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.

Newswise: Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Released: 17-May-2024 1:05 PM EDT
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Washington University in St. Louis

A study by researchers at Washington University School of Medicine in St. Louis has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19, as well as related coronaviruses.

Newswise: Vivek%20Kumar%20with%20hydrogels-resize.jpg?itok=Ls_qh5Tc
Released: 17-May-2024 1:05 PM EDT
NJIT Engineers Muffle Invading Pathogens with a 'Molecular Mask'
New Jersey Institute of Technology (NJIT)

Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their effectiveness and even render them obsolete.

   
Newswise: New Electrostatic Sampler Boosts Indoor Virus Detection Speed
Released: 16-May-2024 8:25 AM EDT
New Electrostatic Sampler Boosts Indoor Virus Detection Speed
Chinese Academy of Sciences

Researchers have developed a groundbreaking electrostatic air sampler that enhances the rapid monitoring of airborne influenza and coronavirus. The device, capable of high air flow rates, offers significant advancements in detecting viral presence in indoor environments through polymerase chain reaction (PCR) analysis.

   
Released: 15-May-2024 9:05 AM EDT
What Dog Owners Should Know About Leptospirosis
Tufts University

Leptospirosis is an illness caused by a bacteria called leptospira that can be present in soil and stagnant water. Rodents and other wildlife carry the bacteria and spread it through their urine. Both humans and dogs can become sick with leptospirosis, while cats are considered disease-resistant. For both people and dogs, the result of infection can range from mild to deadly serious.

   
Newswise: Social distancing plus vaccines prevented 800,000 COVID deaths - but at great cost
Released: 14-May-2024 2:05 PM EDT
Social distancing plus vaccines prevented 800,000 COVID deaths - but at great cost
University of Colorado Boulder

Changing people’s behavior until a vaccine could be developed prevented roughly 800,000 COVID-19 deaths in the U.S., according to new CU Boulder and UCLA research. But the authors stress that interventions like lockdowns and school closures came at great economic and social cost.

Released: 13-May-2024 3:05 PM EDT
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutchinson Cancer Center

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.

Released: 13-May-2024 3:05 PM EDT
Texas Tech Researchers Help Confirm First Case of Avian Influenza Transmitted from Cow to Human
Texas Tech University

Researchers from the Biological Threat Response Laboratory played a critical role in testing for the virus.

Released: 13-May-2024 9:05 AM EDT
Negotiations for a Global Pandemic Agreement Extended
Wildlife Conservation Society

Member States of the World Health Organization (WHO) were due to converge on text for a global pandemic agreement during their ninth and final negotiating session in March; however, insufficient progress was made in those two weeks, in terms of finding consensus.

Newswise: 3i Symposium Inspires Interdisciplinary Insights in Immunology, Inflammation, and Infection
Released: 9-May-2024 5:05 PM EDT
3i Symposium Inspires Interdisciplinary Insights in Immunology, Inflammation, and Infection
University of Utah Health

Over 150 researchers from across the University of Utah gathered to form new connections and share groundbreaking research on topics from antibiotic resistance to autoimmune diseases.

   
Newswise: An Entirely New COVID-Related Syndrome
Released: 9-May-2024 12:05 PM EDT
An Entirely New COVID-Related Syndrome
University of California San Diego

A group of UC San Diego researchers, centered at UC San Diego's Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.

Released: 9-May-2024 10:00 AM EDT
Shruti Mehta, Infectious Disease Epidemiologist, Named Chair of Johns Hopkins Bloomberg School of Public Health Epidemiology Department
Johns Hopkins Bloomberg School of Public Health

Shruti Mehta, PhD, MPH, has been named The Dr. Charles Armstrong Chair in Epidemiology and Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, effective June 1.

Released: 26-Apr-2024 12:05 PM EDT
Texas Biomed Researching Vaccines and Treatments for Highly Pathogenic Avian Influenza
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

Released: 26-Apr-2024 12:00 PM EDT
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
World Journal of Stem Cells

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

Released: 26-Apr-2024 10:05 AM EDT
New Tool Helps Identify Babies at High-Risk for RSV
Vanderbilt University Medical Center

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.



close
4.39653